Journal of Immunology and Clinical Microbiology

AIM

The Journal of Immunology and Clinical Microbiology

• The Journal of Immunology and Clinical Microbiology (JICM) is a free international peer-reviewed journal that publishes original articles, case reports, reviews and analyzes in both written and visual forms*.
• JICM aims to serve as a free scientific journal in all fields related to immunology, microbiology, rheumatology and pathogenesis, diagnosis, treatment of infectious diseases and general medicine.
• It is a journal covering studies in immunology, clinical microbiology and general medicine.
• Journal of Immunology and Clinical Microbiology is a journal covering the following research topics.

• Immunology and Clinical Microbiology and General Medicine • Adaptive immune system • Allergy • Antimicrobials and immunity • Antigen-antibody interactions • Autoimmunity • Applied microbiology and biotechnology • Bacterial pathogens and infections • Cancer immunology • Clinical immunology • Diagnosis of infectious pathogens (molecular and conventional) • Diagnosis of infectious pathogens (molecular and conventional) • Immune system • Immunogenetics • Immunopharmacology • Immunotherapy and vaccines • Infection surveillance

• Infections Related to Organ Systems • Infections Related to Organ Systems • New diagnostic methods in microbiology • Pathology (infection, immune system) • Patofizyoloji (enfeksiyon, bağışıklık sistemi) • Parasitic pathogens (Protozoa, Helminth ve Arthropod Vectors) • Pediatric Infections • Rheumatology • Transplantation immunology • Treatment of infectious diseases • Treatment methods affecting the immune system (Traditional and complementary medicine) • Viral pathogens and infections • Other immune system disorders • Other pathogens and infections • Traditional and Complementary Medicine • General Medicine • Medical Nutrition

The types of articles to consider are as follows.

• Original Article (Research Article)
• Review
• Short / Mini examination
• Case reports
• Technical note
• Editor / Short contact letter • Editor
• Hypothesis
• Field Report / National and International Reports
• Video Article
• Medical Education


In addition, JICM publishes peer-reviewed scientific "video articles".

** Publishes academic studies in both written and visual forms (video articles).

• The Journal of Immunology and Clinical Microbiology (JICM) is an international peer-reviewed journal. It publishes video article versions in addition to the classic article types (optional).
• It is the first text and video magazine of Türkiye.

SCOPE

Journal of Immunology and Clinical Microbiology;

• Increases scientific research and publication literacy,
• Provides the sharing of qualified and original research results in accordance with scientific norms and scientific ethics,
• Continues its publication life with the aim of developing and strengthening communication on the scientific platform.
• Additionally aims to improve health-related issues globally, to protect and develop public health, to strengthen the medical profession, to increase awareness of holistic treatments, microbiota and nutrition among health professionals.
• Gives priority to the publication of studies on immunology and clinical microbiology.
• Selects its primary target audience from physicians from all branches.
• Has its publication language as Turkish and English.

JICM Editorial Team

AUTHOR GUIDELINES

General Information

Files that need to be uploaded when submitting an article to Dergipark;
(Following files should be sent via the Dergipark system)
1. Cover Letter
2. Title page
3. Article (without authors and links and tables/figures must be embedded in the article)
4. Copyright Transfer Form and Conflict of Interest Form (must be wet-signed, scanned and uploaded in pdf format.)
Please do not send articles by post. All submissions must be uploaded via the online submission system. If there is a problem at this stage, you can send the necessary files by e-mail (Mail: cetuspub@gmail.com).
The editorial office will attach the files to the sending system. In this case, the corresponding author has to indicate the incomplete submission by e-mail.
*Mail Subject: JICM EDITORIAL SUPPORT
We were unable to upload the following files to the submission system. Is it possible for us to complete our submission? (For files larger than 8MB and videos, please use this option)
The following rules should be applied in the articles sent to the journal for publication:
The article should be written in Microsoft Word program, on A4 paper size, with 1.5 cm margins from each side of the paper, with 1.5 line spacing and 12 font size. Research and review articles should not exceed 20 pages, including references and tables/figures. Journal of Immunology and Clinical Microbiology uses the pubmed writing rules system.

JICM Editorial Staff
www.jiacm.com

1. Cover Letter

The author should indicate that the publication is original, that it has not been sent or published in any other journal, the scientific importance of the article and why it should be published, whether it is presented in a paper or other format in an organization such as a congress.

2. Title Page

The cover page should also be uploaded to the system and should not be in the file containing the main text. Information that should be on the cover page:
• The title should be in Turkish and English. The first letters of the words of the Turkish and English titles should be capitalized, bold and centered. The recommended length of the title of the article is 10-12 words.
• A short title in Turkish and English (not exceeding 40 characters)
• Names and Surnames of the Authors
• Degrees of the Authors
• Information regarding the Institution (University, Department, Division, Province and Country must be specified.)
• E-mail
• Orcid Information.

Example:

Qui Quaes: Adana City Training and Research Hospital, Psychiatry Clinic, Adana, Türkiye
Email:
ORCID iD: https://orcid.org/

Under the Statements title, the responsible author information, degree and information regarding the institution should be specified, whether there is any conflict of interest, the persons and organizations that support the study financially and, if any, ethical statements and author contributions should be added under the financial support title.

Conflict of Interest

An example personal statement of no conflict of interest:
[X] The authors declared no conflict of interest regarding this article.

Financial Support:

[X] No financial support was used by the authors during this study.
Or,
[X] This study was funded by the University of ... with the project number 2015/12345.

If submitted as a paper;

[X] A part of this work was presented as an oral/poster paper titled “…” at the “…… Congress” held in … city.

Thesis:

[X] This study was prepared by rearranging the master's thesis and the doctoral dissertation prepared by … under the title of “…”.

Ethical Statement:

For Research Articles;

[X] Ethical approval, dated … and numbered …, was obtained from … University Medical Faculty Clinical/Human Research Ethics Committee for this study, and the rules of the Declaration of Helsinki were followed in the conduct of this study.

For Case Reports;

[X] Informed consent was obtained from the participant and the Declaration of Helsinki guidelines were followed to conduct this study.

For Review Articles;

[X] Since this study is a review article, Ethics Committee approval was not required and the Declaration of Helsinki guidelines were followed in the conduct of this study.

Author Contributions:

Idea: UK, MK, Design: UK, M, Supervision: MK, HD, Equipment: UK, MK, HD, Data collection and processing: MK, HD, Analysis and commentation: MK, HD, Literature review: UK, Writing: UK, Critical review: MK, HD.

All text on the cover page should be written in 12 point Times New Roman font.

REGARDING THE CONTENT OF THE ARTICLE

Introduction

The introduction should be a minimum of 150 and a maximum of 1000 words. In the introduction, authors should highlight the new information in the article, the hypothesis, and the purpose of their work. The introduction should not contain conclusions. The purpose of the study should be stated in the last sentence.

Materials and Methods

This section should contain only the information available at the time the study is scheduled. All information obtained during the study should be given in the Results section. This section should be structured as follows.

• Subjects (if the study includes human subjects)
• Materials and Methods – Statistical Analysis Topics/Materials it is recommended to include the following.
• Time and place of study (start and end dates of study)
• Study design (case-control, cohort, diagnostic accuracy, etc.)

Inclusion and exclusion criteria; relevant demographic and background details (age, gender, diagnostic criteria, etc.)

When reporting experiments on human subjects, authors should indicate whether procedures comply with ethical standards set by the responsible human experimentation committee (institutional and national) and the 1975 Declaration of Helsinki (as revised in 2008).
All subjects must sign an informed consent form and this information should be stated in the manuscript. Signed informed consent forms should be archived by the authors. Authors must provide in a written statement that they have obtained and archived all patient informed consent forms as required in the Author Statement Form. In the Methods section, methods, tools (indicate the manufacturer's name and country in parentheses), and procedures should be described in sufficient detail to allow other researchers to reproduce the results. In the statistical analysis section, the authors should list all statistical methods used in the study and a preselected level of significance (p). If possible, results should be quantified and presented using appropriate indicators of measurement error or uncertainty (eg, confidence intervals). At the end of this section, authors can specify the statistical software used.

Results

State the main or most important result first. Data presented in tables or figures should not be repeated in the text. Charts should be used as an alternative to multi-entry tables; the same data should not be presented in duplicate (for example, in both graphs and tables). Exact P values, rounded to three decimal places, should be provided for all tested differences (for example, replace p<0.05 with p=0.048.

The descriptive statistics (number, percentage, mean, standard deviation, etc.) of the data obtained in the Results section, the statistical tests used, and the test and probability (p) values should be written clearly.

If the ratio is written as “Percentage” in the table captions, the % sign should not be used together.

Discussion

New and important conclusions based on study results should be highlighted in the context of the best available evidence. Data presented in the Introduction or Conclusion section should not be repeated. The limitations of the study should be clearly stated.

Conclusion

This section is a brief conclusion summarizing your key finding and message. It shouldn't be too long or repetitive. It is important not to start new thoughts in your conclusion.
Statements; All contributors who do not meet the authorship criteria should be listed in the Acknowledgments section. These individuals must give verbal consent to be admitted. Authors must provide this statement on the Author Statement Form. Financial and material support should also be acknowledged.

Tables

Brief annotated tables should be placed at the end of the main word file. (.doc/.docx file). Use only the horizontal lines of the table grid. Tables should be numbered consecutively using Arabic numerals. Make sure to refer to each table in the text. Each column should have a short caption and detailed explanation in the footnote. All non-standard abbreviations should be explained in table footnotes using symbols in the following order: *, †, ‡, §, ?, , **, ††, ‡‡, §§, ??, etc.
The table number and the caption of the table should be placed above the table, with the initials of the words in capital letters. Each table must be cited in the text.

• The source should be indicated under the tables, figures and images taken from another source. Permission must be obtained for use.
• Tables should not be larger than one page, large tables should be shortened.
• Abbreviations and related explanations should be explained in 12 points using (*) under tables, figures and graphics.

Figures

Each figure and its short caption should be given in a separate file. Figures should be numbered sequentially in the order they appear in the text. Our technical editors will redesign or recreate all the graphic elements of the article (images, schematic presentations, etc.) if they do not conform to the uniform style of the journal. If figures cannot be added to the article file for any reason, they can be uploaded as separate electronic files.
The accepted image file formats for print publication are: *.jpg, *.bmp or *.tiff; desired resolution is 150 dpi. We strongly recommend using *.tiff format. We recommend using the IrfanView software (free) and its plug-ins to change the format of your figures.
- Figures and images should be given a sequence number and caption, and the first letters of the words in the caption should be written in capital letters.

Language and Style

The article should be written in an understandable style in English and should be checked for correct spelling and grammatical use. The journal does not provide language editing services. We strongly recommend that non-native English-language authors have their articles edited by a linguist or a fluent English speaker before submitting. Please note that this does not guarantee that the article will be accepted for publication. JICM has no preference for the use of any particular "language editing" service providers.
At this point, authors who want to get editing service can contact us (cetuspub@gmail.com) and get the service for a fee.

Appendices

The scales used in the research contain additional information such as questionnaire forms. They should start on a new page.

ARTICLE TYPES

Manuscripts are divided into ten groups according to the following criteria. The selected classification will appear in the printed manuscript above the manuscript title. The editor reserves the right to classify the article as it sees fit.
* Maximum word count DOES NOT include the title, authors and links, summary, keywords, subheadings, table and figure descriptions, and references.

1. Research Articles

• Research Articles will be uploaded separately from the cover page.
• It consists of Turkish and English Abstract, Introduction, Aim, Methods, Results, Discussion, Conclusion, References.
• Tables/figures should be embedded in the article without the authors and links of the article.

* If the author is not a native speaker, a language edit certificate must be uploaded to the Dergipark system for English articles during article submission. (This case is specific to the journal)

Abstract

It should be in the content that will enable the whole study to be understood. It should be written in Turkish and English, and should not exceed a minimum of 150 and a maximum of 250 words. Turkish and English abstracts should be on separate pages.

In Turkish abstracts;

Giriş, Amaç, Yöntem, Bulgular, Sonuç, Anahtar Kelimeler should be given. References should not be cited in the abstract.

In English abstracts; Aim, Methods, Results, Conclusion, Keywords should be given.

Keywords:

• Keywords are one of the most important factors for researchers to be able to find a published article. It is very important that the keywords are suitable for the subject of the article, have sufficient amount, and include the necessary terminology about the cited article and its contribution to science.
• There should be a minimum of 3 and a maximum of 5 keywords in both Turkish and English.
• A comma (,) should be used to separate words.
• English keywords should be given in accordance with "Medical Subject Headings" (http://www.nlm.nih.gov/mesh/MBrowser.html).

If there is anything that the author should specify as content in the abstract, it should be added.

Main Text

Introduction, Materials and Methods, Results, Discussion, Conclusion, References, and Appendices, if any, should be given. Section titles should be in uppercase and sub-headings in lowercase and bold.

2. Review Articles

In the abstract section in Turkish and English, a structure should be created about the importance of the subject, the purpose of writing and the subject it deals with. Turkish abstract should not exceed 200 words.

Keywords should be a minimum of 3 and a maximum of 5 words, and should be written in English and Turkish. The text should consist of Introduction, Body, Conclusion and References.

3. Case Report

The aim/focus of the study and the “case report” should be included in the title.
In the abstract section in Turkish and English, a structure should be created regarding the importance of the case report, the purpose of writing and the subject it deals with. The abstract should be organized in an unstructured manner, without sub-headings, that fully reflects the general content of the subject.

Turkish abstract should not exceed 150-200 words.

Keywords should be between a minimum of 3 and a maximum of 5 words, and should be written in English and Turkish.

The text should consist of Abstract, Introduction, Case Report, Discussion and References. It should be no more than 2000 words.

In the introduction, why the case is important and unique, and the purpose of the case report should be explained.

The case report section should include patient information, main problems and symptoms, past interventions and results, physical examination, clinical findings, diagnostic evaluations, treatment plan, patient follow-up, and appropriate nursing interventions and patient outcomes.

In the discussion section, the relevant literature, the use of the results in practice/contribution to nursing science, the difficulties and limitations of the case report, and the main conclusions drawn from this case report should be included.

• In case reports, it is obligatory to obtain written informed consent from the patient.
• Sufficient number of photographs and diagrams or tables related to the case can be added.

4. Systematic Review

It should be stated in the study title that the article is a systematic review.
In the introduction section in Turkish and English, a structure should be created about the importance of the subject, the purpose of writing and the subject it deals with. The Turkish abstract should not exceed a minimum of 150 and a maximum of 200 words.
Keywords should be between a minimum of 3 and a maximum of 5 words, and should be written in English and Turkish.

The Text should consist of introduction, method, findings, discussion, results, use of results in practice and references.

Rationale/Aim should be explained in line with the literature and the aim/research question of the study should be stated using the PICOS (population, intervention, comparison, outcomes, and study design) framework.

In the Methods section, it should be stated that this is a systematic review, and the eligibility criteria of the studies to be included, the problem of the studies, the interventions and their comparisons should be explained.

In the Results section, the characteristics of the extracted data (sample size, PICOS, follow-up time) for each study should be stated. All results should be cited for each study included in the systematic review.

In the Discussion section, it is necessary to summarize the main results within the framework of the research question and purpose, and discuss the strength of the evidence (for example, considering its relevance to healthcare providers, healthcare recipients, and policy makers).

In the Limitations section, limitations at the level of screening, study and results should be stated.

In the Conclusion section, it is expected that a general interpretation of the results in the context of other evidence will be made and suggestions for future research will be presented.

1. Petekkaya S, Ayaz N, Dogan M, Oruc M, Oner BS, Gokturk C, et al. Suicidal Death from Pseudoephedrine Sulfate Overdose: A Case Report. Ulutas Med J. 2015; 1(4): 119-121.
2. Nagiyev T, Yula E, Abayli B, Koksal F. Prevalence and genotypes of Helicobacter pylori in gastric biopsy specimens from patients with gastroduodenal pathologies in the Cukurova Region of Turkey. J Clin Microbiol. 2009; 47(12): 4150-4153.

REFERENCES

The Journal of Immunology and Clinical Microbiology applies the Pubmed reference style (EndNote Style). In addition, the literature citation must comply with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journal Editors (ICMJE) available at www.ICMJE.org.

• References should be numbered consecutively using numbers in parentheses according to the order of occurrence in the text.

For example:

H. pylori is a gram-negative spiral organism that can colonize the gastric mucosa and is the main cause of chronic active gastritis (2, 4).

• References cited only in tables or figures should be numbered in the order in which they first appear in the text of the table or figure.
• Sources should be verified using an electronic bibliographic source such as PubMed or hard copies from original sources.
• Authors should not add DOI numbers to the end of cited sources.
• Journal titles should be abbreviated according to the style used in the list of Journals Indexed for MEDLINE published by NLM and available at http://www.nlm.nih.gov/tsd/serials/lji.html.
• Examples of various reference formats are available at: http://www.nlm.nih.gov/bsd/uniform_requirements.html

The most common examples are as follows:

For example;

1. Petekkaya S, Ayaz N, Dogan M, Oruc M, Oner BS, Gokturk C, et al. Suicidal Death from Pseudoephedrine Sulfate Overdose: A Case Report. Ulutas Med J. 2015; 1(4): 119-121.
2. Nagiyev T, Yula E, Abayli B, Koksal F. Prevalence and genotypes of Helicobacter pylori in gastric biopsy specimens from patients with gastroduodenal pathologies in the Cukurova Region of Turkey. J Clin Microbiol. 2009; 47(12): 4150-4153.
All authors should be named unless the number of journals exceeds seven, in which case the list is the name of the first six authors followed by "et al.".

Book;

Burtis CA, Ashwood ER, Burns DE, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. St. Louis, MO: Elsevier Saunders, 2006. Book chapter: In English: Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, eds. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.

Internet Research;

Cahill, J., Barkham, M., Hardy, G., Rees, A., Shapiro, D.A., Stiles, W.B. & Macaskill, N. Outcomes of patients completing and not completing cognitive therapy for depression [Electronic version]. British Journal of Clinical Psychology, 2003:42;133-43. Accessed July 19, 2003, from http://www.bps.org.uk/publications/jCP_1.cfm.

References in the Text

The Journal of Immunology and Clinical Microbiology uses the Pubmed reference style. In addition, Crossref source control is done.

* References should include especially the last five years, if necessary, much older sources can be used in reviews. If a source is the main source, cannot be dispensed with and must be cited, then older sources can be used.

References should be cited in the main text in numerical order and in parentheses. All authors should be listed when there are six or fewer references; when there are seven or more, only the first three authors should be listed, followed by "et al".

Index Medicus (abbreviated) abbreviations should be used for journal names. "Submitted" articles should not be cited; these can be specified in the body of the text. Personal communications should be cited in text only by giving them source, date, and type (if e-mail, sender's address should be indicated).

References must conform to the style defined by the International Committee of Medical Journal Editors.

References in the References Section

At the end of the text, references should be given in a separate list in the references section. A maximum of 45 references should be cited in the articles.

Considerations in the Journal Publication Process

1. If the responsible author of the article is informed about the technical correction and writing rules three times, but the requested correction is not made, the article is removed from the evaluation process and this issue is conveyed to the author.
2. Authors are given 4 weeks for minor and major reviewer suggestions.
3. Suggestions from the reviewers should be uploaded to the system by painting different colors on the text and writing the corrections as a text.
4. The author(s) are not informed about the number of publications of the accepted article.
5. The final version of the accepted article is sent to the responsible author for approval before it is published as a pdf template. No changes can be made after approval.
6. While informing the author(s) about the articles to be rejected, the opinions of the reviewers are added to the information mail.
7. Article evaluation period is at least 6 months.
8. Reviewers are given 7 days to accept article review invitations and 30 days to evaluate the article.
9. In case of problems in uploading the revised article to the system, the relevant field editor or secretary should be contacted. The article should not be uploaded to the system again as a new article.

ETHICAL PRINCIPLES AND PUBLICATION POLICY

Studies submitted to the journal for publication should not have been previously published, accepted or evaluated in a journal as a full-text paper or article.

Studies published abroad can be sent to the journal for evaluation by obtaining written permission from the editor of the published journal. Studies presented in a congress or symposium should be indicated in the cover letter.
For the articles to be sent to our journal, a maximum of 20% plagiarism report (iThenticate scan) is expected from the authors "Excluding Abstract, Bibliography, Tables and Figures".
This report will be written and uploaded to the system by the journal publisher "Cetus Publishing" based on the article file sent by the author.
It is obligatory to upload the ethics committee approval and the copyright transfer form of the article, which were obtained within the last five years, to the system.
JICM can be accessed free of charge via the Dergipark Platform in open access and full-text storable format. Instructions for authors are in line with "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publications" (www.ICMJE.org, updated on April 2010).
Please note that the Editors reserve the right to make any necessary changes to the language and style of the original article to comply with the Journal's uniform standards.
Please ensure that you prepare your article in accordance with JICM's general requirements for articles and our specific recommendations on the different article types below.
Please strictly follow these guidelines. Failure to follow these guidelines will delay the editorial and peer-review process and increase the feedback time.
All research submitted for publication in the journal must comply with the Declaration of Helsinki, Guide for the Care and Use of Laboratory Animals, COPE and ICMJE.
It should be noted that informed consent was obtained from the participants in the submitted studies. It should also be noted that informed consent was obtained from those who are primarily responsible on behalf of individuals (children, comatose patients, etc.) who are incapable of making a decision.
The compliance of the articles with ethical, scientific, legal, etc. rules is the responsibility of the authors. Applications of articles that are under evaluation in another journal are not accepted. The author(s) accept(s) that they have not applied for evaluation of the article in another journal at the application stage, otherwise all responsibility belong to the author(s). The journal reserves the right to take necessary official actions.

Policies & Statements

• Terms of Use
• Privacy Policy
• Editorial Policy
• Authors Rights and Obligations
• Publication Ethics and Publication Malpractice Statement
• Conflict of Interest Policy
• Protection of Research Participants (Statement On Human And Animal Rights)
• Advertising Policy
• Editorial & Peer Review Process

Terms of Use

General

These Terms of Use govern your access to and use of digital products and services owned by the Journal of Immunology and Clinical Microbiology (JICM) and its subsidiaries, including but not limited to the offical website (www.jiacm.com), unless other terms and conditions apply.

Copyright Ownership and Permitted Use

Unless otherwise indicated, the content available through the JICM services (and publisher QMEL.org) are protected by copyright and may be used only in accordance with the Creative Commons Attribution-Noncommercial License and other applicable laws. Content available through the JICM services is approved only for your personal noncommercial use. JICM reserves the right to limit, suspend or terminate your access to and use of the JICM sites at any time without notice.

Trademark Ownership

Journal logos and name design are trademarks of the JICM (The publisher QMEL.org). Any use of JICM (and the publisher QMEL.org) trademarks in connection with the sale, offering for sale, distribution or advertising of any goods or services, which is likely to cause confusion, to cause a mistake, or to deceive, is strictly prohibited.

Disclaimer of Warranties and Liability

Content made available through the JICM services is the result of research and/or contribution by independent individuals or organizations. The JICM is not responsible for or endorses the accuracy or reliability of any data or conclusions reported in such content. All contents are intended for guidance and reference purposes only.

The JICM sites and your access to them are provided on an "as is" and "as available basis" without warranty of any kind, either express or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, and noninfringement. In no event will the JICM, its employees, officers, members, or licensors be liable for any special, incidental, indirect, or consequential damages of any kind, or any damages resulting from the inability to use or the use of the services, whether or not advised of the possibility of damages, or on any theory of liability arising out of or in connection with the use or performance of the services.

User-Submitted Content

The following provisions apply to all article submitters to the JICM in connection with its journals and other related services. By submitting content you agree to the following provisions, which may be amended periodically:
1. You agree that you are fully responsible for the content that you submit. You agree that you will not post or submit any content that violates or encourages the violation of any applicable local, state, national or international law, rule, or regulation, or is otherwise inappropriate.
2. The editors of JICM, in their sole discretion, reserve the right to reject, edit, remove or otherwise alter any content submitted for any reason.
3. Once your submission is published, you will not have the right to have it removed or edited.

Login Security

Sharing login information for the JICM services is strictly prohibited.

International Use

Users are responsible for compliance with all local applicable laws, rules and regulations regarding online conduct and data usage of the country you reside in or access from.

Privacy

You confirm that you have read and accept our Privacy Policy.

Modifications of Terms of Use

JICM reserves the right to modify these Terms of Use at any time. The continued use of the JICM services after any such posting shall constitute acceptance of the Terms of Use as modified.

Service Update and Website Availability

The JICM reserves the right to modify, suspend, discontinue or restrict access to all or any part of the services and website at any time.

Privacy Policy

Journal of Immunology and Clinical Microbiology is committed to the protection of your personal information. The privacy policy outlined here applies only to information collected by JICM through the www.jiacm.com website.

Information We Collect

We will request personal information from you to establish your individual user profile that will support all online activities carried out as an author, editorial board member, or other related role. Information such as your name, postal address, e-mail address, telephone number and geographic locale are used as unique identifiers to allow access to certain content or to a secure site. All personal information is treated by JICM as strictly private and confidential. JICM will not disclose any personal information to third parties without your permission, unless required by law.

Cookies

Cookies and log files are automatically recorded when you visit our site. These data may include some or all of the following information: IP address, host name, domain name, browser version and platform, date and time of requests, and downloaded or viewed files. This information is used to measure and analyze traffic and usage of the JICM websites and our digital products.
Making Changes to Your Information
Once you have created a user account on the JICM website, you can update your personal information at any time through your account settings.
This statement may be periodically updated.

Editorial Policy

JICM has established a guideline for editorial independence as delineated below.

The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE) and the European Association of Science Editors (EASE).

1. Journal of Immunology and Clinical Microbiology is operated by QMEL, which is publishing organization.
2. The General Chief Editor (currently, Erkan YULA, M.D.) is responsible for independent leadership of JICM editorial operations. The General Publishing Editor reports to the Editor-in-Chief (currently, Erkan YULA, M.D) for all editorial matters.
3. JICM has one or more Editor-in-Chief. These Editors-in-Chief each have their own boards.
4. The Editor-in-Chief has full authority over the content of JICM and its related offerings. This includes summaries and comments on recent medical advances, opinions, blogs and news.
5. Content-related decisions are based on quality, importance, and value to the users of JICM. Contributing authors, editors, JICM staff are free to express responsible positions – even if these views are not in agreement with interests, policies or published research, editorial or commentary of QMEL.
6. Each QMEL journal has editorial operations that are completely separate and independent.
7. Any packaging or combined offering of QMEL Journals does not affect the independence of editorial decision-making.
8. JICM actively seeks input regarding editorial matters from the physician Editors-in-Chief in an advisory capacity, as well as from the other editorial board members, internal editorial staff, and readers.
9. Editors-in-Chief of JICM is empowered to create content and commentary free of commercial and organizational influence. All authors and editors operate without conflict of interest and all potential conflicts are disclosed (please also see Conflict of Interest Policy).

Publication Ethics and Publication Malpractice Statement

The publication of an article in a peer reviewed journal is an essential model for our journal "Journal of Immunology and Clinical Microbiology".
It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer(s) and the publisher.
Our ethic statements are based on COPE’s Best Practice Guidelines for Journal Editors.

Publication decisions

The editor is responsible for deciding which of the articles submitted to the journal should be published.
The editor may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editor may confer with other editors or reviewers in making this decision.

Fair play

An editor at any time evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.

Confidentiality

The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

Disclosure and conflicts of interest

Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.

Duties of Reviewers

Contribution to Editorial Decisions

Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper.

Promptness

Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

Confidentiality

Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.

Standards of Objectivity

Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Acknowledgement of Sources

Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and Conflict of Interest

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Duties of Authors :

Reporting standards
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Data Access and Retention

Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Originality and Plagiarism

The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.

Multiple, Redundant or Concurrent Publication

An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.

Acknowledgement of Sources

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.

Authorship of the Paper

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors.
The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Hazards and Human or Animal Subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.

Disclosure and Conflicts of Interest

All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Fundamental errors in published works

When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

Author’s Rights and Obligations

All authors published their research papers in Journal of Immunology and Clinical Microbiology (JICM) are entitled for following rights and obligations:

1. Authors hold full copyright and self archiving rights, they transfer the publishing rights to Journal of Immunology and Clinical Microbiology.
2. We do decline to publish material where a pre-print or working paper has been previously published online.
3. We allow author(s) to get their seminar papers published with a note about the seminar if the paper is not published online.
4. The research and review papers published in Journal of Immunology and Clinical Microbiology can be archived in any private of public archives online or offline. For this purpose authors need to use the final published papers downloaded from http://www.jiacm.com
5. Authors are allowed to archive their article in open access repositories as “post-prints” (Please note that: a post-print is the version incorporating changes and modifications resulting from peer-review comments).
6. The authors need to acknowledge the original reference to the published paper when used in some other format like epub or audio files.
7. Journal of Immunology and Clinical Microbiologyy offers Creative Commons Attribution-Non Commercial-No Derivs 4.0 Unported License to researchers and scholar who uses the content of the published papers.
8. Authors are free to use link to our published papers and share the published papers online or offline in the final format printed on the Journal website.
9. Authors can index and store the published papers in the private or public archives or repositories like university database, internet archived, academia, researchgate etc.
10. We promote sharing of knowledge with due credit to the authors and researchers of the papers published with Journal of Immunology and Clinical Microbiology.

Publication Ethics and Publication Malpractice Statement

Editorial and Peer Review Processes generally follow these steps:

The publication of an article in a peer reviewed journal is an essential model for our journal "Journal of Immunology and Clinical Microbiology (JICM)".
It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer(s) and the publisher.
Our ethic statements are based on COPE’s Best Practice Guidelines for Journal Editors.

Publication decisions

The editor is responsible for deciding which of the articles submitted to the JICM should be published.
The editor may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editor may confer with other editors or reviewers in making this decision.

Fair play

An editor at any time evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.

Confidentiality

The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

Disclosure and conflicts of interest

Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.

Duties of Reviewers :

Contribution to Editorial Decisions:
Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper.

Promptness

Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

Confidentiality

Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.

Standards of Objectivity

Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Acknowledgement of Sources

Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and Conflict of Interest

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Duties of Authors :

Reporting standards
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Data Access and Retention

Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Originality and Plagiarism

The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.

Multiple, Redundant or Concurrent Publication

An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.

Acknowledgement of Sources

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.

Authorship of the Paper

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors.
The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Hazards and Human or Animal Subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.

Disclosure and Conflicts of Interest

All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Fundamental errors in published works

When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

Conflict of Interest Policy

Articles would be published with statements or supporting documents declaring:

- Authors’ conflicts of interest; and
- Sources of support for the work, including sponsor names along with explanations of the role of those sources if any in study design; collection, analysis, and interpretation of data; writing of the report; the decision to submit the report for publication; or a statement declaring that the supporting source had no such involvement; and
- Whether the authors had access to the study data, with an explanation of the nature and extent of access, including whether access is on-going.

To support the above statements, editors may request that authors of a study sponsored by a funder with a proprietary or financial interest in the outcome sign a statement, such as “I had full access to all of the data in this study and I take complete responsibility for the integrity of the data and the accuracy of the data analysis.” Adopted from Conflict of Interest in Peer-Reviewed Medical Journals which is prepared by WAME Editorial Policy and Publication Ethics Committees and UMJ journals (open access no).

Protection of Research Participants

(Statement On Human and Animal Rights)

When reporting experiments on people, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national), or if no formal ethics committee is available, with the Helsinki Declaration as revised in 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Patient consent should be written and archived with the journal, the authors, or both, as dictated by local regulations or laws. Applicable laws vary from locale to locale, and journals should establish their own policies with legal guidance. Since a journal that archives the consent will be aware of patient identity, some journals may decide that patient confidentiality is better guarded by having the author archive the consent and instead providing the journal with a written statement that attests that they have received and archived written patient consent.

Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are de-identified, authors should provide assurance, and editors should so note, that such changes do not distort scientific meaning.

The requirement for informed consent should be included in the journal’s instructions for authors. When informed consent has been obtained, it should be indicated in the published article.

When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare. Adapted from ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals and UMJ journals (open access no).

Advertising Policy

The JICM accepts advertising for their hard copies, web sites and related e-mail services (e-mail alerts) according to the following principles:

Advertising must be separate from content. Content may not be altered, added, or deleted to accommodate advertising. Advertisers have no input regarding any of our editorial decisions or advertising policies. The advertising sales representatives have neither control over, nor prior knowledge of, specific editorial content before it is published.

The JICM reserves the right to decline or cancel any advertisement at any time.

Third-party advertisements may not use The JICM name, logo, or title on their web pages or email alerts.

Advertised products must be compliant with the regulations in the country where the advertisement will be seen. Advertisements for pharmaceutical products (including new drug applications) that are subject to U.S. Food and Drug Administration oversight must comply with FDA regulations regarding advertising and promotion.

Users will be able to distinguish advertising and editorial content clearly on the web site and in e-mail alerts. Commercial advertising does not appear on the same screen as editorial content on the web site or in full-content e-mails.

Advertisers have no control or influence over the results of searches a user may conduct on Journal web pages.

Editorial and Peer Review Processes

Editorial and Peer Review Processes of Journal of Immunology and Clinical Microbiology generally follow these steps:
1. We follow and request from authors, reviewers and editors the "ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals".
2. When an article is submitted to Journal of Immunology and Clinical Microbiology, Editor makes the first check of submitted articles (structure, plagiarism, scientific quality).
3. Articles may be rejected, sent back for structural revision, or sent to at least two reviewers for peer review.
4. After peer review process, articles may be rejected, sent back for revision requested by reviewers or accepted for publication.
5. Revised articles by authors may be accepted, resent to reviewers, resent to authors for additional corrections/revision or rejected.
6. Authors cannot see reviewers’ information. Editor may make authors’ information available to reviewers or not.
7. Accepted articles are forwarded to publishing process.
8. Editor(s) may require additional materials or changes from authors during copy editing, composing, grammatical editing and/or proof reading steps. Adapted from UMJ journals (open access no),

Last updated: May 18, 2016

No fee is charged.